UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended FEBRUARY 28, 2003
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________________ to ______________________
Commission File No. 0-11488
PENFORD CORPORATION
(Exact name of registrant as specified in its charter)
WASHINGTON 91-1221360
- ---------------------------------------- -----------------------
(State of Incorporation) (I.R.S. Employer
Identification No.)
7094 SOUTH REVERE PARKWAY,
ENGLEWOOD, COLORADO 80112-3932
- ---------------------------------------- -----------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (303) 649-1900
Indicate by a check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes [X] No [ ]
The number of shares of the Registrant's common stock (the Registrant's only
outstanding class of stock) outstanding as of April 10, 2003 was 8,512,753.
PENFORD CORPORATION AND SUBSIDIARIES
INDEX
<Table>
<Caption>
Page
----
PART I--FINANCIAL INFORMATION
Item 1. Financial Statements
Condensed Consolidated Balance Sheets - February 28, 2003 and August 31, 2002 3
Condensed Consolidated Statements of Income - Three Months and Six Months ended
February 28, 2003 and 2002 4
Condensed Consolidated Statements of Cash Flow - Six Months ended February 28, 2003 and 2002 5
Notes to Condensed Consolidated Financial Statements 6
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 11
Item 3. Quantitative and Qualitative Disclosures about Market Risk 14
Item 4. Controls and Procedures 14
PART II--OTHER INFORMATION
Item 4. Submission of Matters to a Vote of Security Holders 15
Item 6. Exhibits and Reports on Form 8-K 15
Signatures 16
Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 17
</Table>
2
PART I - FINANCIAL INFORMATION
ITEM 1: FINANCIAL STATEMENTS
PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
<Table>
<Caption>
February 28, August 31,
(In thousands, except share and per share data) 2003 2002
- ----------------------------------------------- ------------ ------------
(Unaudited)
ASSETS
Current assets:
Cash $ 3,182 $ --
Trade accounts receivable 32,496 29,744
Inventories 25,584 27,956
Prepaid expenses and other 7,154 5,171
------------ ------------
Total current assets 68,416 62,871
Property, plant and equipment, net 130,138 132,042
Deferred income taxes 10,465 10,375
Restricted cash value of life insurance 11,854 11,705
Goodwill, net 17,367 15,850
Other assets 6,166 6,362
------------ ------------
Total assets $ 244,406 $ 239,205
============ ============
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Bank overdraft, net $ -- $ 989
Accounts payable 19,147 17,161
Accrued liabilities 10,818 10,872
Current portion of long-term debt 69,352 18,779
------------ ------------
Total current liabilities 99,317 47,801
Long-term debt 20,933 77,632
Other postretirement benefits 11,369 11,240
Deferred income taxes 19,706 20,474
Other liabilities 14,977 13,094
------------ ------------
Total liabilities 166,302 170,241
Shareholders' equity:
Preferred stock, par value $1.00 per share, authorized 1,000,000 shares,
none issued -- --
Common stock, par value $1.00 per share, authorized 29,000,000 shares,
issued 9,793,720 and 9,666,149 shares, respectively 9,794 9,666
Additional paid-in capital 27,249 26,055
Retained earnings 71,460 67,513
Treasury stock, at cost, 1,981,016 shares (32,757) (32,757)
Accumulated other comprehensive income (loss) 2,358 (1,513)
------------ ------------
Total shareholders' equity 78,104 68,964
------------ ------------
Total liabilities and shareholders' equity $ 244,406 $ 239,205
============ ============
</Table>
The accompanying notes are an integral part of these statements.
3
PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
<Table>
<Caption>
Three months ended Six months ended
February 28, February 28,
------------------------------ ------------------------------
(In thousands except share and per share data) 2003 2002 2003 2002
- ---------------------------------------------- ------------ ------------ ------------ ------------
Sales $ 61,692 $ 54,837 $ 127,734 $ 111,142
Cost of sales 51,145 44,773 105,302 90,880
------------ ------------ ------------ ------------
Gross margin 10,547 10,064 22,432 20,262
Operating expenses 5,813 5,346 12,180 10,060
Research and development expenses 1,336 1,450 2,748 3,021
Restructure costs, net (117) 1,383 (117) 1,383
------------ ------------ ------------ ------------
Income from operations 3,515 1,885 7,621 5,798
Non-operating income, net 269 21 2,181 44
Interest expense 1,403 1,732 2,984 3,822
------------ ------------ ------------ ------------
Income before income taxes 2,381 174 6,818 2,020
Income taxes 796 30 1,935 636
------------ ------------ ------------ ------------
Net income $ 1,585 $ 144 4,883 $ 1,384
============ ============ ============ ============
Weighted average common shares and equivalents outstanding:
Basic 7,802,724 7,556,052 7,754,674 7,543,627
Diluted 7,934,858 7,735,320 7,902,764 7,668,426
Earnings per share:
Basic $ 0.20 $ 0.02 $ 0.63 $ 0.18
Diluted $ 0.20 $ 0.02 $ 0.62 $ 0.18
Dividends declared per common share $ 0.06 $ 0.06 $ 0.12 $ 0.12
</Table>
The accompanying notes are an integral part of these statements.
4
PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
FOR THE SIX MONTHS ENDED FEBRUARY 28
(Unaudited)
<Table>
<Caption>
(In thousands) 2003 2002
- -------------- ---------- ----------
Cash flows from operating activities:
Net income $ 4,883 $ 1,384
Adjustments to reconcile net income to net cash provided
by operations:
Depreciation and amortization 8,750 8,903
Deferred income taxes (951) (318)
Gain on sale of Hi-maize(R) assets (1,916) --
Other 422 --
Change in assets and liabilities:
Trade receivables (2,804) 1,505
Inventories 3,845 2,865
Accounts payable, prepaids and other 463 (1,481)
---------- ----------
Net cash provided by operating activities 12,692 12,858
---------- ----------
Cash flow provided by (used in) investing activities:
Investment in property, plant and equipment, net (3,260) (2,633)
Proceeds from sale of Hi-maize(R) assets, net 2,054 --
Proceeds from Hi-maize(R) licensing agreement, net 1,653 --
Other (314) 550
---------- ----------
Net cash provided by (used in) investing activities 133 (2,083)
---------- ----------
Cash flow provided by (used in) financing activities:
Borrowings on revolving lines of credit 17,781 6,989
Repayments on revolving lines of credit (14,333) (9,184)
Repayments of long-term debt (12,345) (7,483)
Issuance of common stock 953 574
Payment of dividends (929) (904)
---------- ----------
Net cash used in financing activities (8,873) (10,008)
---------- ----------
Effect of exchange rate changes on cash and cash equivalents 219 (60)
---------- ----------
Net increase in cash and cash equivalents 4,171 707
Cash and cash equivalents (bank overdrafts), net at beginning of period (989) (1,776)
---------- ----------
Cash and cash equivalents (bank overdrafts), net at end of period $ 3,182 $ (1,069)
========== ==========
</Table>
The accompanying notes are an integral part of these statements.
5
PENFORD CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1--BUSINESS
Penford Corporation ("Penford" or the "Company") is in the business of
developing, manufacturing and marketing specialty natural-based ingredient
systems for various applications, including papermaking, textiles and food
products. The Company operates manufacturing facilities in the United States,
Australia, and New Zealand. Penford's products provide excellent binding and
film-forming characteristics that make customers' products better through
natural, convenient and cost effective solutions. Sales of the Company's
products are generated using a combination of direct sales and distributor
agreements.
The Company has extensive research and development capabilities, which
are used in understanding the complex chemistry of carbohydrate-based materials
and their application. In addition, the Company has specialty processing
capabilities for a variety of modified starches.
2--BASIS OF PRESENTATION
The accompanying condensed consolidated financial statements include
the accounts of Penford and its wholly-owned subsidiaries. All material
intercompany transactions and balances have been eliminated. The condensed
consolidated balance sheet at February 28, 2003 and the condensed consolidated
statements of income and cash flows for the interim periods ended February 28,
2003 and 2002 have been prepared by the Company without audit. In the opinion of
management, all adjustments, consisting only of normal recurring adjustments,
that are necessary to present fairly the financial information have been made.
Certain information and footnote disclosures normally included in financial
statements, prepared in accordance with generally accepted accounting
principles, have been condensed or omitted pursuant to the rules and regulations
of the Securities and Exchange Commission ("SEC"). The results of operations for
interim periods are not necessarily indicative of the operating results of a
full year or of future operations. Certain prior period amounts have been
reclassified to conform with the current period presentation. The accompanying
condensed consolidated financial statements should be read in conjunction with
the consolidated financial statements included in the Company's Annual Report on
Form 10-K for the year ended August 31, 2002.
Effective September 1, 2002, the Company adopted Statement of Financial
Accounting Standards ("SFAS") No. 144, "Accounting for Impairment or Disposal of
Long-Lived Assets." SFAS No. 144, which supercedes SFAS No. 121, "Accounting for
the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed
of," retains the fundamental provisions with respect to the recognition and
measurement of long-lived asset impairment but does not apply to goodwill and
other intangible assets. However, SFAS No. 144 provides expanded guidance with
respect to appropriate cash flows to be used to determine whether recognition of
any long-lived asset impairment is required, and if required, how to measure the
amount of the impairment. SFAS No. 144 also requires that any net assets to be
disposed of by sale be reported at the lower of carrying value or fair value
less cost to sell, and expands the reporting of discontinued operations. The
adoption of SFAS No. 144 had no effect on the Company's results of operations,
financial position or liquidity.
Effective September 1, 2002, the Company adopted SFAS No. 145,
"Recission of Financial Accounting Standards Board ("FASB") Statement No. 4, 44,
and 62, Amendment of FASB Statement No. 13, and Technical Corrections." Among
other things, this statement rescinds SFAS No. 4, "Reporting Gains and Losses
from Extinguishment of Debt," which requires all gains and losses from
extinguishments of debt to be aggregated and, if material, classified as an
extraordinary item, net of related income tax effect. As a result, Accounting
Principles Board Opinion No. 30, "Reporting the Results of Operations--Reporting
the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual
and Infrequently Occurring Events and Transactions" will now be used to classify
those gains and losses. The adoption of SFAS No. 145 had no effect on the
Company's financial position or results of operations for the three and six
month periods ended February 28, 2003.
6
Effective January 1, 2003, the Company adopted SFAS No. 146,
"Accounting for Costs Associated with Exit or Disposal Activities." SFAS No. 146
requires that a liability for costs associated with exit or disposal activities
be recognized and measured initially at fair value only when the liability is
incurred. SFAS No. 146 is effective for exit or disposal activities that are
initiated after December 31, 2002. The adoption of SFAS No. 146 did not have an
effect on the Company's financial position, results of operations or liquidity.
Effective December 1, 2002, the Company adopted FASB Interpretation No.
45, "Guarantor's Accounting and Disclosure Requirements for Guarantees,
Including Indirect Guarantees of Indebtedness of Others" ("FIN No. 45"). FIN No.
45 requires certain disclosures to be made by a guarantor effective for interim
and annual periods ending after December 15, 2002. FIN No. 45 also requires the
guarantor to recognize, at the inception of a guarantee, a liability for the
fair value of the obligation relating to the guarantee. The initial recognition
and measurement provisions of FIN No. 45 are applicable on a prospective basis
to guarantees issued or modified after December 31, 2002. The adoption of FIN
No. 45 had no effect on the Company's reported financial position, results of
operations or liquidity.
Effective March 1, 2003, the Company will adopt the disclosure
alternative prescribed by SFAS No. 123, "Accounting for Stock-Based
Compensation," as amended by SFAS No. 148, "Accounting for Stock-Based
Compensation - Transition and Disclosure." The Company will continue to account
for its stock-based employee compensation related to stock options in accordance
with APB Opinion No. 25, "Accounting for Stock Issued to Employees" and its
various interpretations. SFAS No. 148 requires prominent disclosure of the
method used to account for stock-based employee compensation, the amount of
employee stock-based compensation cost included in reported net income, and pro
forma net income and earnings per share as if the fair value recognition
provisions of SFAS No. 123 had been adopted. SFAS No. 148 is effective for
interim periods beginning after December 15, 2002. The adoption of SFAS No. 148
will not have an effect on the Company's reported financial position, results of
operations or liquidity.
3--INVENTORIES
The components of inventory are as follows:
<Table>
<Caption>
February 28, August 31,
2003 2002
------------ ------------
(In thousands)
Raw materials and other $ 10,487 $ 14,250
Work in progress 575 597
Finished goods 14,522 13,109
------------ ------------
Total inventories $ 25,584 $ 27,956
============ ============
</Table>
4--PROPERTY, PLANT AND EQUIPMENT
<Table>
<Caption>
February 28, August 31,
2003 2002
------------ ------------
(In thousands)
Land $ 13,885 $ 13,153
Plant and equipment 274,330 267,837
Construction in progress 4,895 5,415
------------ ------------
293,110 286,405
Accumulated depreciation (162,972) (154,363)
------------ ------------
Net property, plant and equipment $ 130,138 $ 132,042
============ ============
</Table>
7
5--RESTRUCTURING RESERVE
In the second quarter of fiscal 2002, the Company announced a strategic
restructuring of its business operations, including the relocation of its
headquarters from the State of Washington to Colorado. During fiscal 2002, the
Company recorded restructuring costs totaling $1,383,000 related to severance
and other relocation expenses. The restructuring covers seven employees, one of
which had been terminated as of August 31, 2002. Five additional employees were
terminated during the first half of fiscal 2003. In the second quarter of fiscal
2003, the Company settled its lease obligations for less cost than had been
expected and, therefore, adjusted the restructuring reserve. The following table
is an analysis of the restructuring reserve for the six months ended February
28, 2003.
<Table>
<Caption>
Employee Lease Termination
Costs and Other Total
-------- ----------------- -------
(In thousands)
Balance, August 31, 2002 $ 1,014 $ 264 $ 1,278
Payments (371) (100) (471)
Adjustment -- (117) (117)
-------- ------- -------
Balance, February 28, 2003 $ 643 $ 47 $ 690
======== ======= =======
</Table>
6--DEBT
On November 26, 2002, the Company's banks approved an amendment to the
Company's credit agreements to modify the leverage ratio and to reduce scheduled
term loan payments in fiscal 2003 to reflect the current operating environment
and to ensure continued availability of credit. The Company was in compliance
with the amended covenants and expects to be in compliance for the remainder of
the fiscal year.
Pursuant to the Company's credit agreements dated November 2000, the
revolving lines of credit expire on October 31, 2003. Therefore, $51.0 million
of amounts due on these lines of credit at February 28, 2003 has been classified
as current maturities of long-term debt in the Condensed Consolidated Balance
Sheets. The Company expects to refinance its revolving credit agreements on or
before the maturity date.
In September 2000, Penford Australia, a wholly-owned subsidiary of the
Company, obtained a revolving credit facility to finance grain inventory
purchases from a bank in Australia. Also in September 2000, as security for the
credit facility, the Company entered into a guarantee with the bank in
Australia. The credit facility is also secured by the grain in inventory. The
guarantee continues until maturity of the credit facility in September 2003. The
maximum amount of future payments under the guarantee is the current outstanding
balance of the credit facility, $4.1 million and $6.6 million at February 28,
2003 and August 31, 2002, respectively, plus accrued interest and fees. The
outstanding balances of the credit facility are included in current portion of
long-term debt in the Condensed Consolidated Balance Sheets.
7--TAXES
The Company's effective tax rate for the three and six months ended
February 28, 2003 varied from the U.S. federal statutory rate due to lower
foreign tax rates and a lower tax rate applied as a result of the sale of
certain assets of the Company's Hi-maize(R) business in Australia as discussed
in Note 11.
8
8--OTHER COMPREHENSIVE INCOME (LOSS)
The components of total comprehensive income are as follows:
<Table>
<Caption>
Three months ended Six months ended
February 28, February 28,
------------------------- -------------------------
2003 2002 2003 2002
---------- ---------- ---------- ----------
(In thousands)
Net income $ 1,585 $ 144 $ 4,883 $ 1,384
Foreign currency translation adjustments 3,056 131 3,808 (884)
Change in unrealized gains (losses) on derivative
instruments that qualify as cash flow hedges 415 -- 63 (31)
---------- ---------- ---------- ----------
Total comprehensive income $ 5,056 $ 275 $ 8,754 $ 469
========== ========== ========== ==========
</Table>
9--SEGMENT REPORTING
Financial information for the Company's three segments is presented
below. The first two segments, Industrial Ingredients--North America and Food
Ingredients--North America, are broad categories of end-market users, primarily
served by the Company's U.S. operation. The third segment is the Company's
geographically separate operations in Australia and New Zealand, which are
engaged primarily in the food ingredients business. A fourth item for "corporate
and other" activity is presented to provide reconciliation to amounts reported
in the condensed consolidated financial statements. Corporate and other
represents the activities related to the corporate headquarters such as public
company reporting, personnel costs of the executive management team,
corporate-wide professional services and elimination and consolidation entries.
Intercompany sales of $277,000 and $336,000 in the three and six month periods
ended February 28, 2003 between Australia/New Zealand operations and Food
Ingredients--North America are eliminated in corporate and other since the chief
operating decision maker views segment results prior to intercompany
eliminations. There were no intercompany sales in the three or six months ended
February 28, 2002.
<Table>
<Caption>
Three months ended Six months ended
February 28, February 28,
-------------------------- --------------------------
2003 2002 2003 2002
---------- ---------- ---------- ----------
(In thousands)
Sales:
Industrial Ingredients--North America $ 33,672 $ 30,398 $ 69,360 $ 59,870
Food Ingredients--North America 10,953 10,610 22,463 22,116
Australia/New Zealand operations 17,344 13,829 36,247 29,156
Corporate and other (277) -- (336) --
---------- ---------- ---------- ----------
$ 61,692 $ 54,837 $ 127,734 $ 111,142
========== ========== ========== ==========
Income (loss) from operations:
Industrial Ingredients--North America $ 2,396 $ 2,216 $ 5,200 $ 3,570
Food Ingredients--North America 1,685 1,538 3,385 3,408
Australia/New Zealand operations 1,017 957 2,465 2,509
Corporate and other (1,700) (1,443) (3,546) (2,306)
Restructuring costs, net 117 (1,383) 117 (1,383)
---------- ---------- ---------- ----------
$ 3,515 $ 1,885 $ 7,621 $ 5,798
========== ========== ========== ==========
</Table>
9
10--EARNINGS PER SHARE
Basic earnings per share reflects only the weighted average common
shares outstanding during the period. Diluted earnings per share reflects
weighted average common shares outstanding and the effect of any dilutive common
stock equivalent shares. The following table presents the computation of diluted
weighted average shares outstanding for the three and six month periods ended
February 28, 2003 and 2002.
<Table>
<Caption>
Three months ended Six months ended
February 28, February 28,
------------------------- -------------------------
2003 2002 2003 2002
---------- ---------- ---------- ----------
Weighted average common shares outstanding 7,802,724 7,556,052 7,754,674 7,543,627
Dilutive stock options 132,134 179,268 148,090 124,799
---------- ---------- ---------- ----------
Weighted average common shares,
outstanding, assuming dilution 7,934,858 7,735,320 7,902,764 7,668,426
========== ========== ========== ==========
</Table>
11--NATIONAL STARCH
In November 2002, the Company sold certain assets of its resistant
starch Hi-maize(R) business to National Starch Corporation ("National Starch"),
a wholly-owned subsidiary of ICI of the U.K., for $2.5 million. The Company
recorded a $1.9 million pre-tax gain on the sale of these assets, which gain is
included in net non-operating income in the Condensed Consolidated Statements of
Income for the six months ended February 28, 2003.
The Company also licensed to National Starch the exclusive rights to
its resistant starch intellectual property portfolio for applications in human
nutrition. The Company retained the rights to practice its resistant starch
intellectual property for all non-human nutrition applications. Under the terms
of the licensing agreement, the Company received an initial licensing fee of
$2.25 million ($1.6 million net of transaction expenses) which is being
amortized over the life of the royalty agreement. In addition, the Company will
receive annual royalty payments for a period of seven years or until a maximum
of $11.0 million in royalties is received by the Company.
The Company also entered into a tolling arrangement under which the
Company will manufacture resistant starch products for National Starch, if
requested by National Starch.
12--ISSUANCE OF COMMON STOCK
On March 14, 2003, the Company sold 650,000 shares of its common stock
to the T. Rowe Price Small-Cap Value Fund at $11.11 per share. In March 2003,
approximately $6.8 million of the proceeds were used to reduce the Company's
term loans outstanding.
10
ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
FORWARD-LOOKING STATEMENTS
Investors should read the following discussion and analysis in conjunction with
the consolidated financial statements and notes thereto included elsewhere in
this report. In addition to historical information, the following discussion and
statements found in the Notes to the Condensed Consolidated Financial Statements
contain certain forward-looking statements within the meaning of Section 21E of
the Securities and Exchange Act, as amended, that involve known and unknown
risks and uncertainties, such as statements of Penford's plans, objectives,
expectations and intentions, including the Company's expectation to be in
compliance with its amended debt covenants, the expectation that the Company
will be able to refinance its revolving credit agreement on or before the
maturity date, the expectation that the Company will not need to increase
borrowings in the normal course of operations for the remainder of the fiscal
year and the expectation that the Company will not incur additional compensation
expenses related to its outgoing officers. You should read the cautionary
statements made in this report as being applicable to all related
forward-looking statements wherever they appear in this report. Forward-looking
statements typically can be identified by the use of words such as "believes,"
"intends," "may," "will," "looks," "should," "could," "anticipates," "expects,"
"estimates" or comparable terminology or by strategies or trends, although some
forward-looking statements are expressed differently. Finally, there may be
other factors not mentioned above or included in our SEC filings that may cause
our actual results to differ materially from those in any forward-looking
statement such as global economic conditions and additional threatened terrorist
attacks and responses thereto, including war. You should not rely on these
forward-looking statements, which reflect only the Company's opinion as of the
date of this report. We do not assume any obligation to revise forward-looking
statements.
RESULTS OF OPERATIONS
Results of operations for the Company's three segments are presented
below. The first two segments, Industrial Ingredients--North America and Food
Ingredients--North America, are broad categories of end-market users, primarily
served by the Company's U.S. operation. The third segment is the Company's
geographically separate operations in Australia and New Zealand, which are
engaged primarily in the food ingredients business, although the industrial
market is an important and growing category there. A fourth item for "corporate
and other" activity is presented to provide reconciliation to amounts reported
in the consolidated financial statements. Corporate and other represents the
activities related to the corporate headquarters such as public company
reporting, personnel costs of the executive management team, corporate-wide
professional services and elimination and consolidation entries.
Sales
Consolidated sales for the three months ended February 28, 2003
increased $6.9 million, or 13%, to $61.7 million from $54.8 million for the
three months ended February 28, 2002. Consolidated sales for the six months
ended February 28, 2003 rose to $127.7 million, an increase of 15% over the same
period in the prior year.
Sales at the Company's Industrial Ingredients--North America business
unit increased by $3.3 million, or 11%, in the second quarter of fiscal 2003
compared to the year-ago quarter. Sales for the six months ended February 28,
2003 increased $9.5 million over the same period in the prior year. The increase
in sales during fiscal 2003 is due to growth in sales volumes, reflecting
improving demand for the Company's paper customers' products.
Sales at Penford's Australia/New Zealand operations rose by 25%, or
$3.5 million, in the second quarter of fiscal 2003 compared to the same quarter
of fiscal 2002. Sales for the six months ended February 28, 2003 increased to
$36.2 million, or a 24% increase over the same period last year. Approximately
half of the increase in sales in the three and six month periods of fiscal 2003
is attributable to favorable foreign currency exchange rates. The remainder of
the increase is reflective of prior price increases as well as improved volumes
and product mix.
11
The Food Ingredients--North America sales in the second quarter of
fiscal 2003 increased by 3% compared to the prior year period and sales for the
six months ended February 28, 2003 were comparable to the same period a year
ago. The slight change in sales is reflective of the soft customer demand in the
quick service restaurant business, the primary end market for many of this
segment's products.
Income from operations
Consolidated income from operations increased by $1.6 and $1.8 million
for the three and six month periods in fiscal 2003 compared to the same periods
last year. During the second quarter of fiscal 2002, the Company recorded a $1.4
million restructuring reserve and in the second quarter of fiscal 2003 reduced
the reserve by $0.1 million, as discussed in Note 5 to the Condensed
Consolidated Financial Statements. Excluding net restructuring costs, the
increases in consolidated income from operations for the three and six month
periods of fiscal 2003 are $0.1 million and $0.3 million, respectively. Revenue
growth due to an increase in volumes and favorable currency exchange rates was
offset by higher costs of natural gas and grain as discussed below.
Income from operations at the Company's Industrial Ingredients--North
America business unit rose $0.2 million and $1.6 million, respectively, for the
second quarter and first half of fiscal 2003 primarily on higher sales volumes
combined with improved plant overhead absorption, and lower chemical costs
offset by higher natural gas costs.
Penford's Australia/New Zealand operating income for both the three and
six months ended February 28, 2003 was comparable to the prior year. Higher
sales were offset by significantly higher raw material grain costs caused by the
continuing drought in the region.
The Food Ingredients--North American business unit recorded an increase
in income from operations of $0.1 million in the second quarter of fiscal 2003
primarily due to reductions in personnel. Income from operations for the six
months ended February 28, 2003 was comparable to the same period in 2002.
Corporate operating expenses increased approximately $0.3 million and
$1.2 million, respectively, for the three and six months ended February 28, 2003
compared to the same periods in the prior year. During the first quarter of
fiscal 2003, the Company incurred increased compensation expenses for both
current and outgoing officers of the Company which have not continued in the
second quarter.
Interest expense and taxes
Interest expense decreased 19% and 22%, respectively, for the three and
six month periods ended February 28, 2003 compared to the same periods in the
prior year. The decrease in interest expense is attributable to lower debt
balances and favorable interest rates.
The Company's effective tax rate for the three and six months ended
February 28, 2003 varied from the U.S. federal statutory rate due to the effect
of lower statutory tax rates in Australia and a lower tax rate applied as a
result of the sale of certain assets of the Company's Hi-maize(R) business in
Australia as discussed below.
Restructuring costs
In the second quarter of fiscal 2002, the Company announced a strategic
restructuring of its business operations, including the relocation of its
headquarters from the State of Washington to Colorado. During the second quarter
of 2002, the Company recorded restructuring costs totaling $1.4 million related
to severance and other relocation expenses. In the second quarter of fiscal
2003, the Company settled its lease obligations for less cost than had been
expected and adjusted the restructuring reserve by $0.1 million.
12
Non-operating income, net
Non-operating income, net increased for the six months ended February
28, 2003 due to the $1.9 pretax gain on the sale of certain assets of the
Company's resistant starch Hi-maize(R) business to National Starch Corporation
in November 2002.
LIQUIDITY AND CAPITAL RESOURCES
At February 28, 2003, the Company had $30.9 million in negative working
capital compared to $15.1 million of positive working capital at August 31,
2002. Excluding the current portion of the Company's revolving and term credit
agreement, the Company had $34.3 million of positive working capital at February
28, 2003. Cash flow from operations was $12.7 million and $12.9 million for the
six months ended February 28, 2003 and 2002, respectively.
Cash flow from investing activities increased approximately $2.2
million for the six months ended February 28, 2003 compared to the same period
in 2002. The increase is primarily due to the receipts of cash related to the
Company's sale of certain assets of its Hi-maize(R) business and an upfront
licensing fee for the use of certain intellectual property, partially offset by
an increase in capital expenditures.
At February 28, 2003, the Company had $55.1 million outstanding under
its revolving credit facilities and Australian inventory financing credit
agreement. The Company's revolving lines of credit mature October 31, 2003.
Therefore, $51.0 million due on these lines of credit at February 28, 2003 has
been classified as current maturities of long-term debt. The Company expects to
refinance its revolving credit agreements on or before the maturity date.
Under the amended financial covenants of its credit agreements, the
Company is required over the coming fiscal quarters to improve its leverage
ratio (the ratio of the debt balance to the trailing four quarters of earnings
before interest, taxes, depreciation and amortization). The Company has limited
ability to borrow on available capacity under its existing credit lines until
the leverage ratio improves. However, the Company does not expect to increase
borrowings, other than seasonal borrowing related to grain purchasing in our
Australia/New Zealand operations. The Company anticipates that it will have
sufficient borrowing capacity and availability on its credit lines to fund those
seasonal grain purchases.
The financial covenants in the Company's credit agreement also restrict
new indebtedness, require maintenance of minimum tangible net worth and limit
annual capital expenditures to $15 million for fiscal 2003. In addition to the
leverage ratio, the Company is also required to maintain interest coverage and
fixed charges coverage ratios. If earnings fall below projected levels, the
Company may be required to limit capital expenditures and/or dividends. The
Company was in compliance with the amended covenants and expects to be in
compliance for the remainder of the fiscal year.
On March 14, 2003, the Company sold 650,000 shares of its common stock
to an accredited investor for $11.11 per share. In March 2003, approximately
$6.8 million of the proceeds were used to reduce the Company's term loans
outstanding.
During the six months ended February 28, 2003, the Company paid
dividends of $0.9 million, comparable to the dividend payment in the same period
last year. Any future dividends will be paid at the discretion of the Company's
board of directors and will depend upon, among other things, earnings, financial
condition, cash requirements and availability, and contractual requirements.
13
ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The market risk associated with the Company's market risk sensitive
instruments is the potential loss from adverse changes in interest rates,
foreign currency exchange rates, and commodities prices. The Company is unaware
of any material changes to the market risk disclosures referred to in the
Company's Report on Form 10-K for the year ended August 31, 2002.
ITEM 4: CONTROLS AND PROCEDURES
Penford management, including the Chief Executive Officer and Chief
Financial Officer, have conducted an evaluation of the effectiveness of
disclosure controls and procedures pursuant to Rule 13a-14(c) of the Securities
Exchange Act of 1934 within 90 days prior to the date of this report. Based on
that evaluation, the Chief Executive Officer and Chief Financial Officer
concluded that the disclosure controls and procedures are effective in ensuring
that all material information required to be filed in this quarterly report has
been made known to them in a timely fashion. There have been no significant
changes in internal controls, or in factors that could significantly affect
internal controls, subsequent to the date the Chief Executive Officer and Chief
Financial Officers completed their evaluation.
14
PART II - OTHER INFORMATION
ITEM 4: SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
The Company held its Annual Meeting of Shareholders on January 22,
2003. The only item voted upon at the meeting was the election of directors. The
results of the election are shown below. Directors not elected at this meeting
and whose term of office continued after the meeting are Jeffrey T. Cook, Thomas
D. Malkoski, Sally G. Narodick, John C. Hunter III and James E. Warjone.
<Table>
<Caption>
Percent of Percent of
Director Votes For Voted Votes Withheld Voted
-------- --------- ---------- -------------- ----------
Richard T. Crowder 6,436,515 94.2% 393,666 5.8%
Paul H. Hatfield 6,414,052 93.9% 416,129 6.1%
</Table>
ITEM 6: EXHIBITS AND REPORTS ON FORM 8-K.
(a) Exhibits
99.1 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002
99.2 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002
(b) Reports on Forms 8-K.
A Form 8-K was filed on March 20, 2003, reporting Registrant's
issuance of common stock. Filed as an exhibit was a press release
dated March 20, 2003.
15
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Penford Corporation
------------------------------------------
(Registrant)
April 14, 2003 /s/ Steven O. Cordier
------------------------------------------
Steven O. Cordier
Vice President and Chief Financial Officer
16
CHIEF EXECUTIVE OFFICER CERTIFICATION
I, Thomas D. Malkoski, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Penford Corporation;
2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by
this quarterly report;
3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all
material respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in this
quarterly report;
4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:
a) designed such disclosure controls and procedures to ensure that
material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this
quarterly report is begin prepared;
b) evaluated the effectiveness of the registrant's disclosure
controls and procedures as of a date within 90 days prior to the
filing date of this quarterly report (the "Evaluation Date"); and
c) presented in this quarterly report our conclusions about the
effectiveness of the disclosure controls and procedures based on
our evaluation as of the Evaluation Date;
5. The registrant's other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit
committee of registrant's board of directors (or persons performing the
equivalent function):
a) All significant deficiencies in the design or operation of
internal controls which could adversely affect the registrant's
ability to record, process, summarize and report financial data
and have identified for the registrant's auditors any material
weaknesses in internal controls; and
b) Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's
internal controls; and
6. The registrant's other certifying officers and I have indicated in this
quarterly report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal
controls subsequent to the date of our most recent evaluation, including
any corrective actions with regard to significant deficiencies and material
weaknesses.
PENFORD CORPORATION
Date: April 14, 2003 /s/ THOMAS D. MALKOSKI
-----------------------------------------
Thomas D. Malkoski
Chief Executive Officer
17
CHIEF FINANCIAL OFFICER CERTIFICATION
I, Steven O. Cordier, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Penford Corporation;
2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by
this quarterly report;
3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all
material respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in this
quarterly report;
4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:
a) designed such disclosure controls and procedures to ensure that
material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this
quarterly report is begin prepared;
b) evaluated the effectiveness of the registrant's disclosure
controls and procedures as of a date within 90 days prior to the
filing date of this quarterly report (the "Evaluation Date"); and
c) presented in this quarterly report our conclusions about the
effectiveness of the disclosure controls and procedures based on
our evaluation as of the Evaluation Date;
5. The registrant's other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit
committee of registrant's board of directors (or persons performing the
equivalent function):
a) All significant deficiencies in the design or operation of
internal controls which could adversely affect the registrant's
ability to record, process, summarize and report financial data
and have identified for the registrant's auditors any material
weaknesses in internal controls; and
b) Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's
internal controls; and
6. The registrant's other certifying officers and I have indicated in this
quarterly report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal
controls subsequent to the date of our most recent evaluation, including
any corrective actions with regard to significant deficiencies and material
weaknesses.
PENFORD CORPORATION
Date: April 14, 2003 /s/ STEVEN O. CORDIER
-----------------------------------------
Steven O. Cordier
Chief Financial Officer
18